» Articles » PMID: 25524845

Memory, Executive Function and Language Function Are Similarly Impaired in Both Temporal and Extra Temporal Refractory Epilepsy-A Prospective Study

Overview
Journal Epilepsy Res
Specialty Neurology
Date 2014 Dec 20
PMID 25524845
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cognitive impairment has long been recognized as a co-morbidity or sequel to refractory epilepsy. This study was conducted to evaluate the degree and selectivity of involvement of memory, language and executive functions performance among patients with temporal (TLE) versus extratemporal epilepsy (ETLE).

Methods: We prospectively enrolled adolescent and adult patients with medically refractory focal epilepsy, who had undergone pre-surgical evaluation. Language, memory and executive function assessment was done using Western Aphasia Battery, PGI memory scale and battery of four executive function tests (trail making test A & B, digit symbol test, Stroop Task and verbal fluency test), respectively.

Results: Among102 patients enrolled (TLE-59, ETLE-43), mean age of patients 23.0 4± 8.3 years, 83 (82%) had impairment of more than one cognitive domain and 21 (21%) had all three domains involved. Severely impaired memory scores were found in 8.6% patients with MTLE-HS, 8% of the rest of the patients with TLE and 7% patients with ETLE. The differences in the mean scores were also not found statistically significant (p=0.669). Naming impairment was the most common language abnormality, although all aphasia subscores were similar for the ETLE and TLE groups. Executive function impairment was the most common cognitive domain affected. Overall performance on executive function tests was found impaired in almost all patients of both groups without any significant inter-group difference, except on Trail-A test, which revealed better results in patients with mTLE-HS as compared to all other sub-groups.

Conclusion: Our study shows that impairment of memory, language and executive function is common among patients with drug refractory epilepsy. The most prevalent impairment is in executive function. There is no significant difference in the degree, prevalence or selectivity of impairment in either of the three domains, between the TLE versus ETLE groups.

Citing Articles

Adiponectin targets the AMPK/mTOR signaling pathway to alleviate cognitive impairment in epilepsy.

Zhang Y, Qu Z, Mao Z, Liu H, Wang W, Jia L Mol Med Rep. 2025; 31(3.

PMID: 39749696 PMC: 11726285. DOI: 10.3892/mmr.2025.13429.


Complex executive functions assessed by the trail making test (TMT) part B improve more than those assessed by the TMT part A or digit span backward task during vagus nerve stimulation in patients with drug-resistant epilepsy.

Lahde N, Basnyat P, Raitanen J, Kamppi L, Lehtimaki K, Rosti-Otajarvi E Front Psychiatry. 2024; 15:1349201.

PMID: 38419904 PMC: 10899669. DOI: 10.3389/fpsyt.2024.1349201.


Longitudinal EpiTrack assessment of executive functions following vagus nerve stimulation therapy in patients with drug-resistant epilepsy.

Lahde N, Basnyat P, Raitanen J, Lehtimaki K, Rosti-Otajarvi E, Peltola J Epilepsia Open. 2023; 9(1):150-163.

PMID: 37897151 PMC: 10839331. DOI: 10.1002/epi4.12855.


Inhibitory dysfunction may cause prospective memory impairment in temporal lobe epilepsy (TLE) patients: an event-related potential study.

Yu H, Gao J, Chang R, Mak W, Thach T, Cheung R Front Hum Neurosci. 2023; 17:1006744.

PMID: 37565055 PMC: 10410078. DOI: 10.3389/fnhum.2023.1006744.


Evaluation of Event-Related Potentials in Assessing Cognitive Functions of Adult Patients with Epilepsy of Unknown Etiology.

Jezowska-Jurczyk K, Jurczyk P, Budrewicz S, Pokryszko-Dragan A J Clin Med. 2023; 12(7).

PMID: 37048584 PMC: 10094758. DOI: 10.3390/jcm12072500.